Norrving, Bo http://orcid.org/0000-0002-8024-5096
Article History
First Online: 8 January 2019
Competing interests
: The author has received honoraria from AstraZeneca and from Bayer for Data Safety Monitoring Board work in the SOCRATES, THALES and NAVIGATE-ESUS trials. He is also editor-in-chief for the <i>European Stroke Journal</i>.